CN1255397C - Lactone category compound of sweetsop as well as new usage in medicines and its preparing method - Google Patents
Lactone category compound of sweetsop as well as new usage in medicines and its preparing method Download PDFInfo
- Publication number
- CN1255397C CN1255397C CN 03111501 CN03111501A CN1255397C CN 1255397 C CN1255397 C CN 1255397C CN 03111501 CN03111501 CN 03111501 CN 03111501 A CN03111501 A CN 03111501A CN 1255397 C CN1255397 C CN 1255397C
- Authority
- CN
- China
- Prior art keywords
- preparation
- extraction
- present
- solvent
- annonaceousacetogenicompounds compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a cherimoya lactone compound, a new medical purpose thereof and a preparation method thereof. The present invention has an accelerating activity for the capacities of extracting glucose from disintegrated C2C12 myoblasts and generating lactic acid and also has the function of reducing sugar. The present invention can be applied singly or combined with suitable excipients to prepare antidiabetic drugs in the form of oral preparation or non-oral preparation for the treatment of II-type or I-type diabetes. The preparation method comprises means of separation of natural plant raw materials, chemical synthesis, etc.; the present invention is prepared by the processes of concentration, extraction, elution, chromatographic separation, etc. The molecule structure of the present invention contains at least one saturated or unsaturated pentabasic lactone ring structure and a long polysubstituted aliphatic chain structure.
Description
Technical field:
The present invention relates to medical technical field, exactly it is a kind of Annonaceousacetogenicompounds compounds and new medical use and preparation method.
Background technology:
Annonaceae (Annona Linn.) plant, ingredient mainly contains type compounds such as Annona lactone (actogenins), vinylbenzene lactone, polyoxy tetrahydrobenzene, alkaloid, flavones and terpene.The focus of research is the anticancer and insecticidal activity of the contained Annonaceousacetogenicompounds compounds of this section plant at present.Since nineteen eighty-two first Annona lactone report, found more than 300 of this compounds so far, be considered to the natural compounds that another class behind the taxol has strong antitumour activity.To be index with the C2C12 sarcoplast of differentiation to the capture functions of glucose and the ability that produces lactic acid carry out the anti-diabetic activity screening to the extract of one over thousands of kind of natural medicinal plant for we, find the stronger extract of several activity, wherein comprised the extract of multiple annonaceae plant.And utilize active method of following the trail of from extracts such as corossol, Jin Pinggena perfume (or spice), to separate to obtain several and have stronger active Annonaceousacetogenicompounds compounds.
Summary of the invention:
The purpose of this invention is to provide Annonaceousacetogenicompounds compounds and new medical use and preparation method, above-claimed cpd is expected to be developed to a kind of novel natural ofhypoglycemic medicine, is used for treatment of diabetes.It is characterized in that: containing at least one saturated or unsaturated five Yuans lactonic ring structures and a long polysubstituted fat chain structure in the Annonaceousacetogenicompounds compounds molecule, can be one of following structure:
Structure I:
R
1Can be CH
3, CH
2OH, CH
2COCH
3In a kind of; R2 or R3 can be a kind of (as when the O, should form carbonyl with the carbon that is connected) among H, O, OH, the OCOCH3; X, m or n can be 0～10.
Structure I I:
R
1Can be CH
3, CH
2OH, CH
2COCH
3In a kind of; M or n can be 0～10.
Structure III:
R
1Can be CH
3, CH
2OH, CH
2COCH
3In a kind of; R
2～R
7, can be O, OH, OCH
3, OCOCH
3In a kind of (when being O, should form carbonyl) with the carbon that is connected; M or n can be 0～10.
Structure I V:
R
1Can be CH
3, CH
2OH, CH
2COCH
3In a kind of; R2～R9 can be a kind of (as when the O, should form carbonyl with the carbon that is connected) among H, O, OH, OCH3, the OCOCH3; M, n, x, y, z can be 0～10.
Structure V:
R
1Can be CH
3, CH
2OH, CH
2COCH
3In a kind of; R
2～R
7, can be H, O, OH, OCH
3, OCOCH
3
In a kind of (when being O, forming carbonyl) with the carbon that is connected; M, n, x, y can be 0～10.
Structure VI:
R
1Can be CH
3, CH
2OH, CH
2COCH
3In a kind of; R
2Or R
3, can be H, O, OH, OCH
3, OCOCH
3In a kind of (when being O, forming carbonyl) with the carbon that is connected; M or n can be 0～10.
Structure VII:
R
1Can be CH
3, CH
2OH, CH
2COCH
3In a kind of; R
2～R
4, can be H, O, OH, OCH
3, OCOCH
3
In a kind of (when being O, forming carbonyl) with the carbon that is connected; M or n can be 0～10.
Structure VIII:
R
1Can be CH
3, CH
2OH, CH
2COCH
3In a kind of; R
2Or R
3, can be H, O, OH, OCH
3, OCOCH
3
In a kind of (when being O, forming carbonyl) with the carbon that is connected; M or n can be 0～10.
Structure I X:
R
1Can be CH
3, CH
2OH, CH
2COCH
3In a kind of; R
2Or R
3, can be H, O, OH, OCH
3, OCOCH
3
In a kind of (when being O, forming carbonyl) with the carbon that is connected; M or n can be 0～10.
The present invention is not limited only to above-mentioned nine kinds of structure types, also should comprise other Annonaceousacetogenicompounds compounds (acetogenins).
The preparation method of Annonaceousacetogenicompounds compounds separates from natural goods, also can be chemosynthesis, also can be to carry out structural modification or bio-transformation etc. on the basis of certain annonaceous acetogenins.Below be the working method when from natural phant, separating Annonaceousacetogenicompounds compounds:
Branches and leaves, trunk, root, pericarp or seed with the annonaceae plant are raw material, adopt solvent-extraction process, and one or both technologies in the technologies such as resin adsorption method are made concentrated extract, use organic solvent extractions such as chloroform, ether then.Extract separates through silica gel column chromatography.The silica gel granularity of filling in the silicagel column can be 60～300 orders (optimum size is 100～200 orders), with hexanaphthene, chloroform, acetone, methyl alcohol etc. form by the eluting solvent wash-out of little polarity to high polarity, the annonaceous acetogenins that contains that obtains is partly utilized high performance liquid chromatography (normal phase silica gel chromatography post or anti-phase ODS chromatographic column) to separate to prepare Annona lactone.
In the solvent-extraction process that is adopted, organic solvents such as optional water or methyl alcohol, ethanol, propyl alcohol, butanols, amylalcohol, acetone, ethyl acetate, ethyl formate, chloroform, methylene dichloride, ether, or two or more mixed solvents that dissolve each other, at room temperature dipping extracts or with the refluxing extraction under supersound extraction or the heated condition.Extraction time can be once, also can be repeatedly.
In the solvent extration that is adopted, the above-mentioned extract that obtains can be suspended in water directly extracts with suitable solvent (butanols, amylalcohol, ethyl acetate, ethyl formate, chloroform, methylene dichloride, ether etc.).Extraction times can be once, also can be repeatedly.
The resin method that is adopted, macroporous adsorbent resin etc.As, water, alcohol or pure water extract can be handled with macroporous adsorbent resin, discard the water elution part, collect pure wash-out part.
The separation method of Annonaceousacetogenicompounds compounds of the present invention comprises that also carbon dioxide upercritical fluid extraction separates.
With the preparation Annonaceousacetogenicompounds compounds as anti-diabetic effective constituent, can use separately or share, or combine with suitable vehicle etc., make oral dosage form or non-oral dosage form (injection, sprays, patch etc.) is applied to treatment of diabetes according to ordinary method.
Advantage of the present invention is: the present invention utilizes Annonaceousacetogenicompounds compounds as the anti-diabetic effective ingredient, has the natural drug characteristics, is expected to be developed to the new type natural ofhypoglycemic medicine, is used for the treatment of II pattern type i diabetes.In addition, technology of the present invention is simple, is easy to amplify, and is convenient to suitability for industrialized production.
Description of drawings:
Fig. 1 is cis-Annonacin of the present invention and arianacin promoter action (n=4) table with test results to the C2C12 cellular uptake glucose that breaks up
Fig. 2 for Leiogenin of the present invention and Gigantriocin to the C2C12 cellular uptake glucose of differentiation and generate promoter action (n=4) table with test results of lactic acid
Embodiment:
Embodiment 1: corossol seed 1kg, pulverize, and with 95% alcohol reflux of 10 times of amounts 2 hours, filtration was concentrated into the semi-solid extract.With water suspendible, chloroform extraction.The silica gel (100～140 order) of gained chloroform extract and triplication is mixed sample, carry out column chromatography, will contain Annonaceousacetogenicompounds compounds and partly carry out high performance liquid chromatography preparation (positive SiO2 filler chromatographic column with the silica gel (100～200 order) of 50 times of amounts; Anti-phase ODS filler chromatographic column) obtains cis-annonacin (32mg), arianacin (14mg) annonacin-10-one (11mg), gigantetronein (6mg), gigantetrocinA (4mg), goniothalamicin (23mg).The gained part of compounds has promoter action to the ability of the C2C12 sarcoplast ingestion of glucose of differentiation, and test result is as shown in table 1.
The plane chemical structure of cis-Annonacin:
The plane chemical structure of Arianacin:
Embodiment 2: the dry root 2kg of Jin Pinggena perfume (or spice) (Goniothalamus Leiocarpus), pulverize, and with the chloroform refluxing extraction of 10 times of amounts 2 hours, filtration was concentrated into the semi-solid extract.Gained is got the silica gel (100～140 order) of thing and triplication and mixed sample, carry out column chromatography, will contain Annonaceousacetogenicompounds compounds and partly carry out high performance liquid chromatography preparation (positive SiO with the silica gel (100～200 order) of 50 times of amounts
2Filler chromatographic column or anti-phase ODS filler chromatographic column) obtain Leiogenin and Gigantriocin.They are to the C2C12 sarcoplast ingestion of glucose of differentiation and to generate the promoter action of lactic acid ability as shown in table 2.
The chemical structure of Leiogenin:
The chemical structure of Gigantriocin:
Claims (7)
1, the application of Annonaceousacetogenicompounds compounds in the preparation antidiabetic medicine, it is characterized in that: with list-tetrahydrofuran (THF) type and non-neighbour two-tetrahydrofuran (THF) type sweetsop in cis-Annonacin, Arianacin, Leiogenin and Gigantriocin in the lipoid substance as the effective ingredient for preparing antidiabetic medicine, can use separately or share or combine, make the antidiabetic medicine of oral dosage form or non-oral dosage form according to ordinary method with the vehicle that suits.
2, the application of Annonaceousacetogenicompounds compounds according to claim 1 in the preparation antidiabetic medicine, it is characterized in that: list-tetrahydrofuran (THF) type and non-neighbour be two-tetrahydrofuran (THF) type sweetsop in cis-Annonacin, Arianacin, Leiogenin and Gigantriocin in the lipoid substance can be isolating from natural goods, also can be chemosynthesis, can also be to carry out structural modification or bio-transformation on the basis of certain annonaceous acetogenins.
3, Annonaceousacetogenicompounds compounds is characterized in that structural formula is as follows:
The plane chemical structure of I:cis-Annonacin:
The plane chemical structure of II:Arianacin:
The chemical structure of III:Leiogenin:
The chemical structure of IV:Gigantriocin:
4, a kind of preparation method of Annonaceousacetogenicompounds compounds as claimed in claim 3, it is characterized in that: with the branches and leaves of annonaceae plant, trunk, root, pericarp or seed are raw material, adopt solvent-extraction process, one or both technologies in the resin adsorption method technology are made concentrated extract, use chloroform then, the ether organic solvent extraction, extract separates through silica gel column chromatography, the silica gel granularity of filling in the silicagel column is 60～300 orders, use hexanaphthene, chloroform, acetone, methyl alcohol form by the eluting solvent wash-out of little polarity to high polarity, the annonaceous acetogenins that contains that obtains is partly utilized high performance liquid chromatography to separate to prepare Annona lactone.
5, the preparation method of Annonaceousacetogenicompounds compounds according to claim 4, it is characterized in that: in the solvent-extraction process that is adopted, select water or methyl alcohol, ethanol, propyl alcohol, butanols, amylalcohol, acetone, ethyl acetate, ethyl formate, chloroform, methylene dichloride, ether organic solvent for use, or two or more mixed solvents that dissolve each other, at room temperature dipping extracts or with the refluxing extraction under supersound extraction or the heated condition, extraction time is an one or many.
6, the preparation method of Annonaceousacetogenicompounds compounds according to claim 4 is characterized in that: in the solvent-extraction process that is adopted, the above-mentioned extract that obtains suspended in water directly extract with suitable solvent, extraction time is an one or many.
7, the preparation method of Annonaceousacetogenicompounds compounds according to claim 4 is characterized in that: resin adsorption method adopts macroporous adsorbent resin to handle, and discards the water elution part, collects pure wash-out part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03111501 CN1255397C (en) | 2003-04-21 | 2003-04-21 | Lactone category compound of sweetsop as well as new usage in medicines and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03111501 CN1255397C (en) | 2003-04-21 | 2003-04-21 | Lactone category compound of sweetsop as well as new usage in medicines and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1445220A CN1445220A (en) | 2003-10-01 |
| CN1255397C true CN1255397C (en) | 2006-05-10 |
Family
ID=27814575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03111501 Expired - Fee Related CN1255397C (en) | 2003-04-21 | 2003-04-21 | Lactone category compound of sweetsop as well as new usage in medicines and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1255397C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101575324B (en) * | 2009-05-15 | 2011-05-25 | 贵州正鑫药业有限公司 | Preparation method for extracting anticancer valid-position medicine SHIKEMOXIN from sweetsop |
| CN106543117B (en) * | 2016-11-10 | 2019-01-22 | 南京中医药大学 | With anti-tumor activity double tetrahydrofuran type Annonaceousacetogenicompounds compounds and the preparation method and application thereof |
| CN106543159B (en) * | 2016-11-10 | 2019-02-05 | 南京中医药大学 | Epoxy type Annonaceousacetogenicompounds compounds with anti-tumor activity and the preparation method and application thereof |
| CN107674065A (en) * | 2017-10-13 | 2018-02-09 | 江苏建康职业学院 | Annonaceous acetogenins and its application with antitumor activity |
| CN107753532A (en) * | 2017-11-07 | 2018-03-06 | 海南医学院 | A kind of soursop root extract and its anti-diabetes use |
| CN111184032B (en) * | 2020-01-10 | 2021-05-07 | 云南农业大学 | Goniothalamus affinis nematode killing extract as well as preparation method and application thereof |
| CN111317750A (en) * | 2020-02-17 | 2020-06-23 | 江苏卫生健康职业学院 | Application of sweetsop seed total lactone in preparing medicine for preventing and treating diabetes |
-
2003
- 2003-04-21 CN CN 03111501 patent/CN1255397C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1445220A (en) | 2003-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1255397C (en) | Lactone category compound of sweetsop as well as new usage in medicines and its preparing method | |
| CN103599144A (en) | Preparation method for effective part of valerianajatamansi epoxy iridoid ester | |
| CN1323797A (en) | Chinese chestnut flower flavone compound and its extraction process | |
| CN111153908B (en) | Azophilic ketone alkaloid with anti-tumor activity, preparation method and application thereof | |
| CN1709417A (en) | Ainsliaea fragrans champ extract and its preparing method | |
| CN1916012A (en) | Method for picking up and separating compound of flavone being as effective content of cinquefoil, and application | |
| CN1771977A (en) | Notoginseng glycol-saponin composition and its prepn and use | |
| CN1189176C (en) | Astragalus root methyl-glycoside composition and preparation method | |
| CN100344300C (en) | Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method | |
| CN1141101C (en) | Chinese medicine for treating hepatitis B and its preparing process | |
| CN1244566C (en) | Method of preparing taxadol from leaf and twing of planted taxus chinensis | |
| CN1250240C (en) | Isatis root extract, and preparing method and use thereof | |
| CN1778807A (en) | Production of Rhizoma Picrorhizae glucoside II monomer and its drug form for treating hepatitis B | |
| CN1228334C (en) | Anti-tumour effective constituent cherimoya essence preparation method | |
| CN1262555C (en) | High purity separating and purifying method for naringin, syinaringin, hesperidin and neohesperidin | |
| CN101036639A (en) | Application of piperlonguminine and dihydropiperlonguminine in the preparation of the medicine for curing senile dementia | |
| CN1069641C (en) | Taxad alcohol cleaning and purifying method | |
| CN1359696A (en) | Process for removing residual agricultural chemical from ginseng | |
| CN1386526A (en) | Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN1274682C (en) | Process for high efficient separating high pureness taxiol half sythesizing precursor | |
| CN1360938A (en) | Nanometer rhinitis-treaitng Qianbai medicine and its prepn | |
| CN1368295A (en) | Nano medicine 'Xiangdan' and its preparing process | |
| CN1634493A (en) | Chinese traditional medicine Tripterygium wilfordii and improving technique for attenuation and synergy of its extract | |
| CN1366905A (en) | Nano jueming blood-fat-reducing preparation medicine and preparation method thereof | |
| CN1362163A (en) | Nano Jieshitong medicine for eliminating stone and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |